AN INTRODUCTION TO CHANGES IN THE OTC DERIVATIVE REGULATORY LANDSCAPE FROM A GLOBAL PERSPECTIVE
| On Tuesday, 13 June 2017, Ashurst's Asia SDG Practice Group Lead Chris Whiteley and Associate Zoe Lam spoke at a seminar hosted by the Hong Kong Corporate Counsel Association (HKCCA) at the law firm's Hong Kong office. The seminar provided an introduction to changes in the OTC derivatives regulatory landscape from a global perspective, including recent regulatory initiatives in the US, EU and Asia. |